Prevalence of Barrett’s Esophagus Remains Low in the Korean Population: Nationwide Cross-Sectional Prospective Multicenter Study
- 198 Downloads
In contrast to the Western population, the prevalence of Barrett’s esophagus (BE) is rare in the Korean population. However, the recent increase in prevalence of gastroesophageal reflux disease (GERD) may affect the prevalence of BE. The aim of this study was to survey the prevalence of BE and evaluate its risk factors.
Patients between 18 and 75 years of age who visited 11 Korean tertiary referral centers between April and July 2006 for routine upper endoscopic examination were surveyed using a symptom questionnaire. Biopsies were performed on the columnar lined epithelium (CLE) of the distal esophagus, and diagnosis was confirmed with detection of specialized intestinal metaplasia.
The study comprised 2,048 patients (mean age 51.4 years, 965 males). The frequency of heartburn or acid regurgitation was 8.7% and 13.1%, respectively. Reflux esophagitis was diagnosed in 10.1% of patients (207 patients); however, most patients had mild reflux. CLE was found in 82 patients; however, only one patient had long-segment CLE. The prevalence of BE was 1% (21 patients). The risk factors for BE were age (P = 0.006), presence of heartburn [odds ratio (OR) 4.33, 95% confidence interval (CI) 1.66–11.34, P = 0.007], acid regurgitation (OR 3.37, 95% CI 1.35–8.42, P = 0.01), sliding hernia (OR 6.21, 95% CI 1.78–21.72, P = 0.001), and reflux esophagitis (OR 10.28, 95% CI 4.31–24.50, P < 0.0001) on univariate analysis. On multivariate analysis, presence of typical reflux symptoms (P = 0.02) and reflux esophagitis (P < 0.001) were significant.
Prevalence of Barrett’s esophagus remains low in Koreans; however, risk of developing BE has increased in patients with GERD symptoms and reflux esophagitis.
KeywordsPrevalence Barrett’s esophagus Korean Gastroesophageal reflux Reflux esophagitis
We thank Eunyoung Kim for data management. This work was funded by grants from The Korean Society of Neurogastroenterology and Motility Jeil Pharm. Co., SK Pharm. Co., and Astra Zeneca Pharm. Co.
- 13.Nah YH, Jang MK, Ryu JK, Song SR. Incidence of esophagitis in gastroesophageal reflux disease (GERD). Korean J Gastroenterol. 1994;14:145–150.Google Scholar
- 14.Youn YH, Kang YW, Ahn SH, Park SK. Prevalence of alteration of reflux esophagitis. Korean J Gastrointest Endosc. 2001;23:144–148.Google Scholar
- 17.Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of the Los Angeles classification. 1999;45:172–180.Google Scholar
- 19.Son JI, Park HJ, Song KS, et al. A single center’s 30 year experience of esophageal adenocarcinoma. Kor J Int Med. 2001;16:250–253.Google Scholar
- 20.Chung JW, Lee GH, Choi KS, et al. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert’s classification. Dis Esophagus 2009; Feb 13 [Epub ahead of print].Google Scholar
- 21.Lim SB, Han SW, Lee MH. Is Barrett esophagus a rare disorder in Korea? Kor J Int Med. 1983;26:570–575.Google Scholar
- 36.Liebermann DA, Oehlke M, Helfand M, The GORGE Consortium. Risk factors for Barrett’s esophagus in community-based practice. Am J Gastroenterol. 1997;92:1293–1297.Google Scholar
- 38.Choi H, Choi MG, Kim SW, et al. Functional gastrointestinal disorders in patients with gastrointestinal symptoms. Kor J Gastroenterol. 1999;33:741–748.Google Scholar